Comments by "SkyRiver" (@SkyRiver1) on "Top U.S. & World Headlines — July 23, 2021" video.
-
8
-
2
-
My understanding is that Mylan and UpJohn merged, to form Viatris. So there is no Mylan anymore.
From wiki: In 2015, Pfizer resurrected the Upjohn name for a division which manufactures and licenses drugs for which patents have expired; as of 2019 it plans to divest itself of this business in 2020.[7]
In July 2019, Pfizer announced plans to merge Upjohn with Mylan, with the new company to be known as Viatris.[8] The merger was expected to close in the first half of 2020, but was delayed due to the COVID-19 pandemic.[9] The merger was completed in November 2020 and the new company was named Viatris.
. . . So Pfizer no longer owns Upjohn, and Upjohn was just a name for it's generic drug division, which they merged with Mylan, another generic manufacturer, and then divested from Pfizer.
I would say there is little hope of punishing Pfizer for a company they do not own, and since Viatris is a generic manufacturer they have no intellectual property.
2
-
1
-
1
-
1